key: cord-0756804-akebwtth
authors: Sberna, Giuseppe; Basile, Flavia; Guarino, Maria Luisa; Capobianchi, Maria Rosaria; Bordi, Licia; Parisi, Gabriella
title: Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
date: 2021-09-29
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.09.069
sha: 3e939cb45ed76e5c0b881da4fe7e22ca4560e3f8
doc_id: 756804
cord_uid: akebwtth

Diagnostic methods based on SARS-CoV-2 antigen detection are promising alternative to SARS-CoV-2 RNA amplification. We evaluated the automated chemiluminescence-based Lumipulse® G SARS-CoV-2 Ag assay as compared to real time assays (combined results from RT-PCR Allplex™ SARS-CoV-2 assay and Easy SARS-CoV-2 WE kit) on 513 nasopharyngeal swabs (NPS). Among these, 53.6% resulted positive to RT-PCR, considered as reference test. Compared to the reference test, overall sensitivity and specificity of Lumipulse® G SARS-CoV-2 Ag assay were 84.0%, and 89.1%, respectively, and overall agreement between the antigen and molecular assays was substantial (κ = 0.727). When stratifying samples into groups based on ranges of RT-PCR cycle threshold (Ct), the antigen test sensitivity was >95% for samples with Ct <30. Linear regression analysis showed strong and highly significant correlation between the Lumipulse Ag concentrations and the RT-PCR Ct values (RdRp gene), irrespective of whether the Ct values from molecular test were combined in a unique regression analysis or analysed separately. Overall, chemiluminescence-based antigen assay may be reliably applied to NPS samples to identify individuals with high viral loads, more likely to transmit the virus.

As COVID-19 continues to strain public health systems and vaccination programmes race against new variants that might be more transmissible or capable of evading immune responses, the urgent need for simple, accessible, and frequent testing remains [Tan SH et al 2021] . Despite molecular assays are considered the gold standard for SARS-CoV-2 diagnosis, antigen detection assays currently deserve great attention, since they are intrinsically less laborious, require a shorter time to results and have the potential to satisfy the pressing demand for early SARS-CoV-2 infection diagnosis, thus allowing to timely adopt prevention measures against the infection spread [Porte L et al 2020; Lambert-Niclot S et al 2020; Kobayashi R et al 2021] . In this study, we compared the performance of Lumipulse® G SARS-CoV-2 Ag assay with two widely used molecular assays (Allplex™ SARS-CoV-2 Assay and Easy SARS-CoV-2 WE kit) using nasopharyngeal swab (NPS) samples consecutively collected for routine diagnosis of SARS-CoV-2 infection.

A total of 513 NPS from individuals seeking for SARS-CoV-2 infection diagnosis [median age: 47 years (range 1-98); 254 males and 259 females] collected during either the admission visit at the San Camillo-Forlanini Hospital or a screening visit at peripheral testing points surrounding this hospital, have been tested in parallel at the hospital Laboratory, using both an automated chemoluninescence-based antigen (Lumipulse® G SARS-CoV-2 Ag assay), and a molecular test (either Allplex™ SARS-CoV-2 Assay, Seegene Inc., Seoul, Republic of Korea or Easy SARS-CoV-2 WE kit, Diatech Pharmacogenetics srl, Jesi, Italy), according to the manufacturer"s instructions.

Data management and analyses were performed using GraphPad Prism version 8.00 (GraphPad Software, La Jolla, CA, USA). The evaluation of the qualitative concordance between results was performed using the weighted Cohen"s kappa statistics and its 95%CI. Correlation analyses were performed using a linear regression analysis. All results were anonymized prior to the analysis here reported. Clinical status information was not available for the Laboratory, and could not be reconstructed after anonymization.

The assay comparison based on anonymized samples has been approved and waived for informed consent signature by the ethical board of National Institute of Infectious Diseases. Table 1) .

When stratifying the Ag test results into groups based on ranges of RT-PCR cycle threshold (Ct), considered an inverse proxy of viral load, the Ag concentration increased in parallel with the extent of viral load, i.e. higher Ag concentration observed in the groups with lower Ct values. Overall, the Ag test sensitivity was >95% for samples with Ct <30; consistently, the median Ag concentration in samples not confirmed by RT-PCR or confirmed with incomplete set of target genes was significantly lower than the median Ag value in samples showing RT-PCR positivity to the complete set of target genes ( Figure 1A ). Linear regression analysis showed an highly significant (r=0.8219, p<0.0001) correlation between the Lumipulse Ag concentrations (Log pg/mL) and Ct values of RdRp gene from the two RT-PCR assays (considered together) ( Figure   1B ). When separately analysed, Allplex™ SARS-CoV-2 Assay showed slightly higher correlation (r=0.9415, p<0.0001) with Lumipulse Ag concentration ( Figure 1C ) as compared to Easy SARS-CoV-2 WE kit (r=0.8836, p<0.0001; Figure 1D ).

Our results are in agreement with previous studies [Menichelli G. et al 2021; Hirotsu Y et al. 2021a; Amendola A et al. 2021; Bordi L et al. 2021; Kobayashi R et al. 2021] and with the recently published article by Hirotsu et al. [Hirotsu et al. 2021b] , showing a satisfactory performance of the Lumipulse G ® SARS-CoV-2 Ag assay for quantitatively measuring the SARS-CoV-2 N antigen concentration in diagnostic samples from infected persons. In the present study the Lumipulse G ® SARS-CoV-2 Ag assay showed 86.4% concordance and substantial agreement with molecular tests, including two broadly used molecular assays (Allplex™ SARS-CoV-2 Assay and Easy SARS-CoV-2 WE kit), with 84.0% overall sensitivity and 89.1% specificity. Notably, when stratifying samples into groups based on ranges of Ct from RT-PCR, the sensitivity of Lumipulse G® SARS-CoV-2 Ag assay was very high (>95%) for samples with low Ct values (<30). It is commonly assumed that these samples most likely derive from persons with active SARS-CoV-2 infection, and are associated with high contagiousness. Linear regression analysis showed highly significant correlation between the Lumipulse Ag concentrations and the Ct values of RdRp gene from both RT-PCR assays.

Overall, the present results support the concept that the chemiluminescence-based antigen assay may be reliably applied to NPS samples to identify individuals with high viral loads, more likely to transmit the virus. 

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. confirmed with complete set of gene, i.e. to 3 genes with the Allplex™ SARS-CoV-2 assay and to 2 genes with the Easy SARS-CoV-2 WE assay (median: 3.11 Log pg/mL); confirmed with incomplete set of gene i.e. to 2 genes with the Allplex™ SARS-CoV-2 assay and to 1 genes with the Easy SARS-CoV-2 WE assay (median: 0.57 Log pg/mL); not confirmed (median: 0.28 Log pg/mL). Statistically significant differences in Student´s T test are indicated in the figure. (B) Correlation between Lumipulse Ag concentrations (Log pg/mL) and Ct values of RdRp gene from the RT-PCR combined results of Allplex™ SARS-CoV-2 Assay and Easy SARS-CoV-2 WE kit (n=513). (C and D) Correlation between Lumipulse Ag concentrations (Log pg/mL) and Ct values of RdRp gene split for from the Allplex™ SARS-CoV-2 Assay (n=387, C) and for the Easy SARS-CoV-2 WE kit (n=126, D). Samples with Ct <40 or pg/mL ≥1.34pg/mL were considered positive. For statistical calculations, an arbitrary value of 41 Ct was assigned to all RT-PCR negative samples and an arbitrary value of 1.0 pg/mL was assigned to all samples with Ag concentration <1.0 pg/mL. *Combined RT-PCR results from Allplex™ SARS-CoV-2 Assay (n=387) and Easy SARS-CoV-2 WE kit (n=126).

Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen

Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: A pilot project

Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR

Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19

Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen

Evaluation of a rapid diagnostic assay for detection of SARS-CoV-2 antigen in nasopharyngeal swabs

Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples

Saliva as a gold-standard sample for SARS-CoV-2 detection